Singapore's Beverly JCG half-year revenue falls 32% on weaker aesthetic medical
Singapore's Beverly JCG half-year revenue falls 32% on weaker aesthetic medical
Overview
Singapore healthcare services provider's half-year revenue fell 32% yr/yr
Gross profit margin held steady at 56%
Outlook
Company plans to commence operations at its newly acquired medical facilities in the fourth quarter of FY2026
Result Drivers
LOWER AESTHETIC MEDICAL REVENUE - Co said revenue declined mainly due to lower revenue from its aesthetic medical and healthcare segment
Company press release: ID:nSN9FcL0f
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
H1 Revenue |
| S$2.98 mln |
|
H1 Gross Margin |
| 56.00% |
|
H1 Gross Profit |
| S$1.68 mln |
|
Reuters Recommended Reads
Aug 12 - Hong Kong's Qianhai Health interim revenue falls on supply constraints
Aug 12 - Singapore's Centurion H1 revenue rises on contributions from Westlite Mandai
Aug 10 - AirSculpt Q2 revenue falls more than expected
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on Beverly Wilshire
See all newsSingapore's Beverly JCG half-year revenue falls 32% on weaker aesthetic medical
Brief: Beverly Wilshire Appoints Chong Meng Fong As CFO
Brief: Beverly Wilshire Says Toh Chiew Khim To Cease As CFO
Brief: Beverly Wilshire Announces Subscription Of 8.5 Million Shares At Issue Price Of S$0.0117 Per Share
Brief: Beverly Wilshire To Issue 8.5 Million New Shares